# Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir

> **NCT05589688** · PHASE1 · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 20 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Acyclovir

## Key facts

- **NCT ID:** NCT05589688
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-09
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589688, "Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05589688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*